The European Commission has agreed with the BSAVA and BVA that controls must be maintained to keep the UK free from the tapeworm Echinococcus multilocularis, and adopted a regulation that will permit pre-movement treatment for dogs travelling to listed Member States (i.e. the UK, Ireland, Finland and Malta).
In June Defra announced that the UK's derogation from European pet travel rules, which allows additional protection for the UK against rabies, ticks and tapeworms, would end on 31 December 2011. The movement rules on rabies and ticks will now be harmonised with the rest of Europe.
However, due to the significant public health risk posed by Echinococcus multilocularis, the BVA and BSAVA (working with Defra, the Federation of Veterinarians of Europe [FVE] and colleagues in Veterinary Ireland) continued to lobby the European Commission for controls on tapeworms to be maintained.
The regulation will ensure that a dog must be treated by a veterinary surgeon 24 to 120 hours (1-5 days) before entering one of the listed countries.
The BVA and BSAVA say they made a scientific case for a treatment window of 24-48 hours, but accept that the Commission had to find a compromise that would assist pet owners travelling during national holidays.
Harvey Locke, President of the BVA said: "This has been a long process but the BVA and BSAVA put forward the strong scientific case for the UK to maintain tapeworm controls and we are delighted that the European Commission has adopted this resolution.
"In our role as guardians of public health, vets were deeply concerned that the removal of tapeworm controls would see the introduction of EM to the UK and Ireland.
"Although relatively benign in dogs, the resulting disease in humans - alveolar echinococcosis - is an invasive, cancer-like cystic stage of the parasite, and is invariably fatal if not treated.
"The next stage of our lobbying will be to ensure that Member States and MEPs from across Europe support the UK's case for the additional controls."
Andrew Ash, President of BSAVA said: "Echinococcus multilocularis is a significant public health threat and we have worked hard to ensure the European Commission understands the potential impact of allowing this zoonotic disease to enter our country.
"The BVA and BSAVA will continue to promote the best possible health and welfare advice for pet owners taking their animals abroad. Our advice to owners is to speak to a vet as early as possible to make sure pets are protected from all diseases and parasites encountered abroad."
The traditional method for detecting equine lameness is subjective, using expert visual evaluation of gait to identify the presence or absence and degree of asymmetries. The lame horse is described as having a disorder, defect or loss of function and this clinical diagnosis has associated welfare implications if the horse is still asked to perform.
The article explains how advanced computer technology is starting to change all this. Optic motion capture or the use of inertial measurement units (IMUs) is now enabling the detailed study and quantification of the horse’s gait; objective assessment against preset thresholds. The paper points out that while these digital systems can overcome the temporal and spatial limitations of the human eye they simply rely on one or a number of set gait parameters to decide about lameness and this can present obstacles.
Thresholds are forcibly based on a limited reference population, which doesn’t adequately reflect the millions of horses in the world. The individual environmental and mental conditions for each horse and its day-to-day gait variations are also not accounted for. On this basis to use the term ‘lame’ because a horse demonstrates a subtle gait alteration, causing it to fall below the threshold, could be inappropriate, particularly as it may not affect the horse’s welfare in any way.
Professor Celia Marr, Editor of the Equine Veterinary Journal said: "An important first step is for researchers and clinicians to start to discriminate clearly between 'asymmetry' and 'lameness' and not to use these as interchangeable terms when interpreting gait analysis data. Asymmetry is often, but not always, a hallmark of lameness, but is not a clinical term, whereas lameness is."
The company says the workshop will provide vets with an opportunity to extend their knowledge of Q Fever, a zoonotic disease that not only affects reproductive performance and productivity in cattle but also presents a health threat to farmers, farming families and related professions such as vets, veterinary technicians and abattoir workers.
The workshop will be presented by Raphaël Guatteo (pictured right), Professor in Bovine Medicine and Health Management at the Veterinary College of Nantes (Oniris) in France.
Raphaël will share his wealth of knowledge on Q Fever including his extensive research into the disease.
He'll answer any questions that delegates may have about Q Fever and will discuss case studies, diagnostic challenges and the importance of quick diagnosis, treatment options and prevention through vaccination.
The Q Fever workshop will take place between 4.00pm and 5.30pm on Thursday 20 October in the Shorthorn Room at the Hilton Metropole in Birmingham.
The workshop is free of charge, but spaces are limited.
Vétoquinol has announced plans to raise £10,000 for The Blue Cross pet charity through sales of Propalin, its fast acting treatment for incontinence in dogs.
From 1st July to 31st December this year, for every 100ml bottle of Propalin ordered, Vétoquinol will give 18p to The Blue Cross and 7p for every 30ml bottle.
To boost the amount raised for The Blue Cross, Vétoquinol is offering vets a free bottle of Propalin for every six bottles ordered of both the 100ml and 30ml sizes.
For example, if you order 18 100ml bottles of Propalin, you will receive 6 free bottles and The Blue Cross will receive £4.32.
Vanessa Rossiter, corporate fundraising officer for The Blue Cross said: “As a charity, The Blue Cross relies on donations to support our adoption centres and animal hospitals around the country. We are very grateful to Vétoquinol for their pledge to raise funds for the hundreds of needy animals in our care.”
According to Vétoquinol, Propalin is the UK’s best selling licensed veterinary treatment for urinary incontinence in the ***. It contains phenylpropanolamine hydrochloride, which acts to increase the tone in muscles that make up the urethal sphincter. It takes effect within 30 minutes of administration and, as a liquid, is highly palatable.
DairyCo has announced the launch of a new programme designed to tackle the challenge of lameness on dairy farms.
The Healthy Feet Programme has been developed to provide a structured approach to assist vets and foot trimmers to work more closely with their farmer clients, to reduce the incidence of lameness on a permanent basis.
DairyCo product manager, Kate Cross said: "We've developed the programme to build on the DairyCo Mobility Score by introducing a programme that dairy farmers can undertake working with their vet who is a trained 'mobility mentor', to identify problems, risk factors and suitable intervention strategies on the farm. An action plan is then agreed to prioritise management practices that have a permanent impact on incidence of lameness."
The programme draws on the findings from the Bristol Healthy Feet Project, the New Zealand Healthy Hooves programme, First Steps and Claw Signals. As well as the valuable experience gained from the DairyCo mastitis plan. It has been designed to combine the best features of all these programmes and aims to build on the successful DairyCo Mobility Score.
Vets are invited to enrol for a two day CPD course, which will enable them to introduce the Healthy Feet Programme to their farmer clients and provide on-going support, assisted by a range of resources provided by DairyCo.
The first course is scheduled for June 2011
For further details please contact Kate Cross on 02476 478686 or email healthyfeet@dairyco.ahdb.org.uk
Virbac has announced that it is to increase production of cat vaccines at its French plants to help practices in the UK manage a shortfall in supply.
The predicted shortfall follows warnings by other manufacturers of stock shortages of between three and six months.
Virbac, which makes the Feligen RCP, Leucogen and Leucofeligen cat vaccines, says it wants to reassure practices that it will do its utmost to ensure continuity of supply during this period and is urging them to order as usual and not stockpile product, which could exacerbate the problem.
Simon Boulton MRCVS, Product Manager for Virbac's vaccine range, said: "Our priority is to keep stock flowing to our existing customers. With this in mind, we've now ceased to supply wholesalers with our cat vaccines. Once wholesaler stocks have been depleted, we ask customers to contact us directly so that stock can be despatched to them from our own warehouse.
By taking this step, we can manage our own stocks effectively and, while we'll be putting our existing customers first, we also stand ready to help supply the rest of the veterinary sector during this period. As a primary manufacturer of vaccines, we're well placed to react quickly to stock shortages and expect to have significantly increased supply by November."
Practices wanting further information should contact their Virbac Territory Manager. Direct orders to the company should be made by calling Virbac on 01359 243243 and selecting Option Three (Direct Orders).
The four-day course, which is organised by Embryonics, will take place in Cheshire and runs from Monday 24 February to Thursday 27 February.
The course will cover the five-step Dutch method of foot trimming, which Ceva says is the most successful tried and tested method of trimming for reducing the incidence of lameness in the herd.
Course tutors include John Dawson MRCVS BVMS CertCHP Dip Cattle footcare and a Ceva representative will also present information on how the management of pain and inflammation fits into a comprehensive lameness treatment programme. The practical course is a recognised route to becoming a NACFT (National Association of Cattle Foot Trimmers) licensed foot trimmer.
Peter Keyte, ruminant business unit manager at Ceva, comments: "We would like to encourage livestock vets, farmers and professional foot trimmers to work more closely together, as a team, to help prevent lameness in cattle. We are therefore delighted to be supporting the industry by sponsoring this course, which will help raise welfare standards across the industry."
For further information on the Professional Foot Trimming course, please visit www.embryonicsltd.co.uk.
According to the company, participating practices more than doubled the number of blood pressure checks they conducted, within 12 months.
The CVS’ clinical improvement project initially looked at how effective its first opinion small animal practices were in screening older cats for hypertension.
In line with the veterinary industry norm, it found that less than two per cent of cats over the age of seven were receiving an annual blood pressure check.
This initial research also found that the common barriers to conducting blood pressure checks by vets and veterinary nurses in practice were due to time constraints, availability of equipment and simply remembering to discuss blood pressure checks with owners.
Each CVS site chose two people to lead the initiative at their site, to aid communication and delivery.
A document was created to help, providing background, aims, summary of resources and planning sections.
Contributory factors preventing delivery of blood pressure checks were outlined and practices were encouraged to identify additional barriers and resources needed.
A suite of resources were then produced to support the practice team - from reception to veterinary surgeons - in improving annual blood pressure check rates.
The resources included new clinical frameworks and veterinary guidelines on how to treat hypertension; in-practice educational resources to highlight the benefits of hypertension screening and information sheets and blood pressure diaries to help clients manage their pets condition.
To upskill and develop colleagues in how to identify and treat hypertension and resulting conditions, a collection of training materials was created and training sessions held.
These included a series of webinars which explained why hypertension is important to identify, how to overcome common challenges encountered when looking for hypertension in cats, how to use the ophthalmic exam to help diagnose hypertension and how to treat hypertension.
Three in-person CPD days were hosted with the support from Ceva six months into the project where feline specialists Sarah Caney and Samantha Taylor shared the latest evidence base in this field and practices were encouraged to share barriers, queries and tips, so that ideas could be taken away to make blood pressure screening a simpler process in practice.
Practices were also encouraged to organise lunch and learn CPD sessions, to share best practice and generate discussion within their team.
In addition, a website was created to host all resources in one place, including webinars, clinical frameworks, client resources, a discussion forum and data.
An audit of each participating practice’s blood pressure check data was conducted at the start of the project.
Results were then shared with each participating practice every month - including the total number of blood pressure checks performed each month and the percentage of cats over the age of seven who had an annual blood pressure check.
Twelve months after its nation-wide launch, results reveal that the number of blood pressure checks have more than doubled (110%) within participating CVS practices and an additional 5,984 blood pressure checks have been performed year on year.
A number of practices were able to implement systems that allowed them to perform over 40 blood pressures each month.
The number of cats on amlodipine (the first choice medication to treat hypertension in cats) increased by 303 patients year-on-year, hinting many more cats had been diagnosed with hypertension.
Kate Allgood, Hub Clinical Lead at CVS who was responsible for the hypertension clinical improvement project, said: “There is a huge benefit in treating hypertension.
"No one wants to see a cat suddenly become blind due to hypertension that wasn’t recognised in time.
"So many associated longer-term feline complications and conditions can be avoided if annual blood pressure checks in cats over the age of seven are routinely performed.
"Increasing blood pressure screening is not a simple task though, and this focus has allowed space and time for practices to give this topic the recognition it deserves; to identify and implement systems that make it easier to identify patients at risk, discuss with clients and perform these checks with ease.
"We have created a robust clinical structure, produced some easily accessible materials and supported our practices to make small and simple changes that add up.
"Our practices have done an outstanding job at delivering this project to date and I look forward to seeing what can be achieved in the future. We strongly believe that this work will contribute towards providing some of the best clinical care for cats in the veterinary profession.”
The original TATE elbow replacement was first in clinical use in the 2010s and the revised 3rd generation version is apparently a much-improved implant, something which the clinical evaluation trial should demonstrate.
Andy Moores, head of the joint replacement programme at The Moores Orthopaedic Clinic, said: “Canine elbow replacement can be a game-changer for dogs living with chronic elbow pain but up until this point the elbow replacement systems have not been as reliable as we would like.
"The third-generation TATE implant has been in use with a small number of US surgeons for several years now and the results so far have been very promising.
"We are delighted that Biomedtrix have invited us to join the evaluation trial for this implant and that the RCVS Ethics Review Panel have approved this.
"We look forward to offering this surgery as an option for some of our most painful canine patients.”
www.mooresortho.com
Horiba Medical has announced it is the official exclusive UK distributor of the fully automated Vet abc Plus+ veterinary haematology analyser from scil animal care company GmbH, Germany.
According to the company, the compact Vet abc Plus+ provides a complete blood count (CBC), including 4-part white blood cell (WBC) differential, from only 10 µl of EDTA whole blood, in only 60 seconds.
The Vet abc Plus+ provides pre-installed settings to analyse samples from dogs, cats, horses, rabbits, mice, rats, cattle, pigs and sheep. For dogs, cats and horses, the Vet abc Plus+ provides a 4-part WBC differential blood count, including a differentiation of the leucocytes to identify lymphocytes, monocytes, granulocytes and eosinophils. Results are available in 60 seconds on screen or can be automatically printed out and transferred to the practice information system or clinical notes. For ease-of-use, the Vet abc Plus+ also incorporates a self-contained reagent and waste system which provides a clean operation whilst being easy to replenish.
Borne from an existing manufacturing partnership, scil and HORIBA Medical already have over 6000 veterinary haematology analysers placed globally. Horiba says the new UK distribution agreement enables UK veterinary professionals to not only procure the Vet abc Plus+ analyser, but also receive expert service and support directly from the manufacturer HORIBA Medical and its team of UK specialists.
For more information, visit: www.horiba.com/uk/medical
A quick survey of VetSurgeon members1 has found that of those that didn't vote in the 2011 council elections, 37.9% 'did not believe that voting in the RCVS elections will have any impact on my working life'
However, as Wynne Richards pointed out, decisions made by the RCVS, or which have involved the RCVS have had a seismic impact on the profession over the years, things like:
... and so on, and so on.
So perhaps the issue is not whether or not the College is relevant to the working lives of its members. Clearly it is. More to the point, the College and its Councillors need to find ways to engage more with the profession and better demonstrate how the decisions it takes on the issues of the day will impact on its members.
This message is further hammered home by the 26% of voters who didn't vote because they: 'considered the candidates' manifestos / forum posts, but did not feel that any of the candidates deserved my vote'. Again, if the councillors had concentrated on explaining why their work would make a difference, perhaps that number could have been improved.
Of the remainder, 21% 'forgot', 8.7% 'didn't have the time to consider who to vote for, and vote', 4.9% gave other reasons. Again, all things which might be improved if members felt that the RCVS was relevant to their working lives.
1% 'weren't aware that the elections were taking place'.
One wonders if that 1% knows that Clement Attlee is no longer the Prime Minister.
1. VetSurgeon Poll 6th May - 8th August 2011. 103 respondents.
A new veterinary charity is offering veterinary surgeons, nurses and others in the profession the chance to get fit and raise money for Hounds for Heroes, SPANA and the Pet Blood Bank later this year.
The Vet Charity Challenge (VCC) is looking for teams to take part in a one-day event, involving a series of physical tasks and puzzle-solving challenges along the way, so it requires a bit of brain as well as brawn. The course will feature walking / running, cycling and kayaking and anyone can take part at whatever fitness level.
As well as raising money for the charities, organisers say it will be a fun way to build up camaraderie among your colleagues outside of the work environment and also a local PR opportunity for your practice or business to enhance your community profile.
The event is expecting to raise in excess of £30,000 for charity, but organisers stress that it will need the support of and participation by the veterinary profession to ensure it is a success.
The challenge will take place on Saturday 15th September 2012 at the Royal Agricultural College, Cirencester and all details may be found on http://www.vetcharitychallenge.co.uk/. Alternatively, ring 01727 859259 for further information. The VCC says an early commitment to take part is essential and the fine detail of training can be worked out later. The VCC will provide training guidelines and help you and your team prepare itself.
The Vet Charity Challenge is sponsored by BCF Technology, Kruuse UK Ltd and Vets 2 and is supported by the VPMA, Mojo Consultancy and JCA Media Group.
HRH The Princess Royal has opened the Animal Health Trust's new cancer treatment and research facility in Suffolk.
The facility has been purpose-built to treat horses, dogs and cats with cancer. It will also assist in furthering understanding of the disease in animals.
Peter Webbon, Chief Executive of the AHT, said: "2012 marks 70 years of the AHT fighting disease and injury in animals, and the addition of the Cancer Centre is a landmark achievement in our history. We believe this is the first facility of its kind in Europe, purpose-built to treat horses, dogs and cats with cancer. We now have a short commissioning process to undertake but anticipate welcoming the first patients through the doors in early 2013."
The Kennel Club Cancer Centre at the AHT houses a linear accelerator (pictured right) and brachytherapy machine used in radiotherapy treatment, along with a 16-slice CT scanner to aid radiotherapy planning.
The new facility complements the AHT's existing cancer treatment options of surgery and chemotherapy meaning the Suffolk-based charity will be able to offer each and every patient the very best options for their specific case, whatever the diagnosis. With one in four dogs and one in six cats developing cancer at some time in their life the new centre will help many more animals fight cancer.
Peter Webbon, added: "It was thanks to a generous donation from the late Tom Scott, a long-term supporter of the AHT, that we were able to start this development. His donation, along with that from many other AHT supporters, and an interest-free loan of £1.5 million from the Kennel Club has meant this ambitious project has come to fruition so quickly."
It has taken just over a year to build the Cancer Centre which contains more than 2,600 tonnes of concrete and has eight-feet wide solid concrete walls.
On opening the facility, HRH The Princess Royal, President of the AHT, said: "This Cancer Centre is an exciting development at the AHT and will make a real difference for animals with cancer, here and now. It will improve the chances, for many animals, of beating this pernicious disease.
"Countless other horses, dogs and cats across the world with cancer, who will never be seen by an AHT clinician, will also benefit from knowledge gained from research in The Kennel Club Cancer Centre at the AHT."
The AHT has a strong history in cancer research and the Kennel Club Cancer Centre will enhance the charity's well established cancer research programme. Knowledge gained through the treatment of animals in the facility will contribute to the study of cancers, their causes, early diagnosis and treatment, and ultimately hopefully the prevention of some forms of the disease.
Steve Dean, Kennel Club Chairman, said: "I am very proud to be here today to celebrate the opening of the Kennel Club Cancer Centre. Thanks to the expertise available here at the Animal Health Trust, the Cancer Centre will provide advanced techniques for the diagnosis and treatment of cancer, to the benefit of many animals. It is exciting to consider how synergy between the Kennel Club Cancer Centre and the Kennel Club Genetics Centre can help to further the understanding of the inheritance factors that influence the development of cancer."
Vetoquinol - makers of the NSAID Cimalgex - has announced the launch of its updated website www.CiMyDog.co.uk.
The company says the website has been developed to provide reliable online information about pain in dogs to cater for the increasing needs of pet owners and vets.
The website has two sections. The first is a pet owner focussed, educational tool which takes the visitor on a journey through the process of pain; from spotting the signs of pain all the way through to ways of relieving pain, culminating in the recommendation that the visitor seeks advice from their veterinary practice.
The second section requires registration as it contains more in depth information on the pain process and potential treatment options available, this section is for veterinary professionals only. Also on this section of the website there are many scientific abstracts related to pain and treatment with links to enable the veterinary visitor can view this peer reviewed material.
Robert Simpson, Cimalgex Product Manager said: "The internet is a very powerful tool in terms of increasing education, especially in areas such as canine pain. Unfortunately there can also be a lot of misinformation online and so we felt it was important for Vetoquinol to try and redress the balance by producing www.CiMyDog.co.uk. This can be used as a reliable and up-to-date resource by pet owners and veterinary professionals alike. -
www.CiMyDog.co.uk is a very interactive site which aims to demystify the pain treatment process, ensure pet owners look out for behavioural signs of pain and looks to improve overall canine health with assistance from their veterinary practice. We hope that this will be a valuable resource to which vets can refer their pet owners."
The study, Urinary incontinence in bitches under primary veterinary care in England: prevalence and risk factors, which will be published in the Journal of Small Animal Practice, also found that other factors such as weight, neuter status and age also play key roles.
The authors hope that the study findings will provide an evidence base that allows veterinary surgeons to enhance their clinical recommendations for higher risk bitches.
The study was based on a population of 100,397 bitches attending 119 veterinary clinics across England. The main findings included:
The study also gave evidence on the welfare impact from urinary incontinence. Almost half of cases (45.6%) received medical therapy for the condition. In addition, of the bitches that died during the study period, urinary incontinence was recorded as either contributory or the main reason for death in 16.7 % of these deaths.
RVC veterinary epidemiologist and VetCompass researcher Dr Dan O’Neill said: "This urinary incontinence study has uncovered dramatic breed predispositions that have previously been hidden to vets and owners.
"Overall, about 3% of bitches were affected but this rose to over 30% in the Irish Setter and over 20% in the Dobermann with many other breeds also predisposed.
"Vets can now use these results to alert owners to typical clinical signs in order to ensure earlier treatment and better outcomes. The study also suggests increased risk in heavier and neutered bitches.
"Following on from this study, a VetCompass Masters project supported by BSAVA PetSavers is working to unravel these associations in order to identify potential preventive strategies, especially in those highly predisposed breeds."
The paper is available in Early View on Wiley Online Library ahead of publication in the JSAP at http://onlinelibrary.wiley.com/doi/10.1111/jsap.12731/full
Reference
Photo: ©Diane Peace Collection / The Kennel Club
For the survey, 565 respondents ranked their levels of concern about different aspects of veterinary life that may be affected by coronavirus.
The top concerns were:
In addition, 42% were very or quite concerned about contracting Covid-19 in their workplace, rising to 55% amongst those working in mixed practice and 50% in small animal/exotic practice.
Respondents were more concerned about stress and burnout amongst their colleagues (67% very or quite concerned) than the impact on themselves (45%), but more than half (58%) of small animal/exotics vets reported being concerned about their own stress and burnout. Managers and employees reported higher levels of concern around stress and burnout than business owners and those who are self-employed.
When it comes to employment, the profession is a bit more optimistic. 23% of respondents are not at all concerned about job security in the veterinary sector, with 43% a little concerned and 31% very or quite concerned. Equine vets (45%) and charity vets (64%) are very or quite concerned about job security in their own sectors, against an average of 23% across all areas of work.
However, 95% of respondents had some level of concern (a little, quite or very) about the potential impact of a recession on the veterinary sector, with government, equine and charity vets most concerned.
The findings will be used to inform BVA’s work on supporting the veterinary profession as the pandemic continues.
BVA President James Russell said: “Although this is just a snapshot survey, it tells us a lot about how our colleagues are feeling six months on from the national lockdown. It paints a worrying, but not surprising, picture about the health and wellbeing of a profession that has worked incredibly hard and in very difficult circumstances this year.
“I’m incredibly proud of the way the profession has adapted to working safely during Covid-19, but we know that it has taken its toll, for example with consults taking longer, needing to cover staff shortages, and dealing with anxious clients.
“BVA also shares the profession’s concerns about the impact on students and new graduates. EMS is the jewel in the crown of UK veterinary teaching and it’s frustrating that opportunities to gain practical training have been hampered by the Covid restrictions. The issue is at the top of our agenda with the RCVS and Vet Schools Council to make sure we can collectively support the next generation of vets through this difficult time.
“As the UK is braced for the second wave, we know we are much better prepared and far more able to work safely to do our bit to tackle the spread of coronavirus. But it’s vital that we continue to support one another, as well as continuing the spirit of collaboration with neighbouring practices that helped us get through the height of the pandemic.
The snapshot survey on Covid-19 is available to view at: https://www.bva.co.uk/media/3781/voice-covid-survey-2020-results.pdf
Annual renewal fees for veterinary surgeons will remain at the same level as in 2021: £364 for UK-practising members, £182 for members practising outside the UK and £60 for non-practising members.
The removal of the alternative fee payment arrangements means there will no longer be the option to pay in instalments and the fee needs to be paid in full by the usual deadline of 1 April.
RCVS Treasurer Niall Connell said: “We understand that many veterinary surgeons and veterinary nurses will have been impacted financially over the last couple of years, and we appreciate that this has been a very difficult time for the professions.
"We are pleased that we are able to keep fees static for a second year running, whilst maintaining a strong programme of strategic projects that help to set, uphold and advance standards within the professions.”
The 2023 PAW Report will assess how lifestyle changes caused by the COVID-19 pandemic and the cost of living crisis have affected the nation’s pets.
The survey, which is open to vets, veterinary nurses and students, closes on 10th February 2023.
Entrants will be in with a chance of winning a £100 One4all voucher, accepted in over 130 high street stores.
Rebecca Ashman, PDSA’s Veterinary Engagement and Communication Manager said: “The PAW Report provides invaluable insight into key areas of pet wellbeing in the UK.
"Lifestyles had to adapt and change through the pandemic, and now as we navigate a cost of living crisis, this research is more vital than ever before.”
Rebecca added: “It takes less than 15 minutes to complete the survey, and by taking part you’ll be helping us maintain an accurate picture of the biggest welfare issues facing pets in the UK today.”
Survey: https://start.yougov.com/refer/vz7hC0lZ0d10nG
RCVS Council recommended the increase due to inflationary pressures and increased business costs.
Dr Tshidi Gardiner MRCVS, RCVS Treasurer, said: “We recognise that these are difficult economic times, so Council has endeavoured to limit the fee increase as far as possible; however, in proposing these new fees, Council has had to take account both of increased costs due to inflation, and of additional costs related to ensuring we are fulfilling our regulatory remit to the best of our abilities and meeting our strategic priorities.
“For example, increased costs related to the additional number of veterinary degrees coming on stream, modernising our membership database, our Charter Case Committee, the trial of our private prosecutions protocol against non-vets breaching the Veterinary Surgeons Act, and much more besides.”
Vets need to pay their annual renewal this year by 1st April.
Anyone who hasn't paid by 1st May will face a late payment charge of £35.
Anyone who hasn't paid by 1st June risks removal from the Register.
As part of the annual renewal process, vets also need to confirm their registration and contact details, declare any convictions and declare they are compliant with the College’s requirements for continuing professional development (CPD).
Anyone who expects to encounter any difficulties in paying their fees is asked to contact the RCVS Finance Team on finance@rcvs.org.uk or 020 7202 0722.
The course has been made available after its authors, Dr Katherine Wakelin and Sarah Corthorne from the University of Surrey, received a Mind Matters Grant to conduct research which found it improved the mental wellbeing of veterinary professionals.
Katherine and Sarah will also be hosting a webinar from 7pm – 8pm on Tuesday 3rd September to discuss the importance of self-compassion, provide an overview of their research, as well as information on the course itself.
Katherine said: “Our recent randomised control trial has shown the course to significantly improve resilience and self-compassion and reduce rumination and self-criticism amongst veterinarians.
"Therefore, Sarah and I are delighted to now be disseminating the CFT course freely to the veterinary profession, so that as many people as possible are able to benefit from the evidence-based resource.
“Even though our research was conducted on veterinary surgeons, we hope that the course will be useful to all those working in the veterinary team as the content can be applied in a number of contexts.
“Our webinar will explain more about our research, as well as some of the science behind the effectiveness of the course in a veterinary context.
"So, if you are interested in learning more about how CFT may be able to help you and your team, both in a personal and professional capacity, please do come along.”
In order to access the online compassion course, individuals are invited to complete a short questionnaire before and after watching one video (10-15 minutes long) each day for 14 days. The aim of the video intervention is to develop self-compassion skills and reduce self-criticism. This will also allow Katherine and Sarah to evaluate the ongoing impact that the videos are having on those working in the sector.
https://vetmindmatters.org/resources/free-online-compassion-course-for-veterinarian-mental-wellbeing/
Inocul8 and the Global Alliance for Livestock Veterinary Medicines (GALVmed), have launched vetvac.org a free new online database of information about livestock and poultry vaccines.
Currently the Vetvac database contains information on nearly 2,000 livestock vaccine products produced by more than 95 manufacturers. This included cattle, sheep, goat, pig and poultry vaccines available in the UK, Australia, Africa, India, South America and the United States. It is being expanded and updated on a continuous basis, and aims to cover all markets, providing the most complete compendium of licensed livestock vaccine products available worldwide.
The database developers say that they hope Vetvac.org will be especially useful to vaccine manufacturers and developers, and animal health professionals and livestock keepers.
Josef Geoola, Vetvac's co-founder, said: "Although there are a number of on-line databases and websites that focus on livestock vaccines, none provide the global coverage that Vetvac.org aims to achieve - our product will be unique."
Zoetis Business Consulting has announced the launch of Profitsolver, a software tool designed to boost practice profits.
The software has already been rolled out in the US, where Zoetis says that it has delivered an average of £103,000 extra profit to veterinary practices within a year.
Profitsolver uses the practice's actual data - not benchmarks or accepted norms - to enable the practice to manage costs, set prices and gain return on investments. By using an activity-based costing model and using a variety of data such as practice costs, which staff perform which part of the procedure, how long the procedure takes and what equipment and materials are used, Profitsolver calculates the correct pricing to both cover costs and deliver a predetermined profit margin.
Zoetis says that Profitsolver helps practices to understand how the overall practice profit is being generated. For instance, for price sensitive procedures such as vaccination, the practice can match their prices with the competition, but maintain their profit margin by increasing the price for other clinical services.
Nick Steele, national consulting manager at Zoetis said: "Veterinary practices have no standard method for pricing their services and they are often unable to determine which services make money and which don't. This hampers the practice's ability to accurately value the business and, as a result, profit levels tend to be low for many practices. Profitsolver can turn this situation around and already has a very successful track record in the US."
Zoetis piloted the UK version of Profitsolver with John Goulding at St Georges Veterinary Group. He said: "By and large the veterinary profession still relies on the mark-up of medicines where profits are concerned. Even practices that have made a concerted effort to move away from this type of pricing structure are still making their money from the sale of medicines rather than from vets' fees. For years I have wanted to know exactly how to price our services and this new Profitsolver software does just that.
"Most costs have an element of staff time, an element of fixed assets or equipment and an element of disposable items. Profitsolver takes all of these into account, adds the predetermined profit margin and produces an accurate pricing structure for each procedure undertaken within the practice.
"It's important to take the time at the start to put accurate data in from the practice's latest set of accounts and the Zoetis business consultant will guide practices through this to make the initial set up as easy as possible. For instance, for major pieces of equipment such as X-ray machines, you have to work out how many times a year you are likely to use them.
"By using Profitsolver, we worked out that if we do exactly the same amount of work as last year we can increase our bottom line by at least £200,000 for our 18 vet practice. Since last November, when we installed Profitsolver, we have completely changed our pricing structure moving away from focusing on medicines and the size of the animal to rethink how we charge our clinical care.
"An unexpected benefit is that Profitsolver has made me much more confident about the prices we charge to clients as it is all broken down, so we can see exactly how the invoice is made up. I would be at a loss without it now."
For more information about Profitsolver, contact your Zoetis account manager.
The Westpoint Group has announced the divestiture of its small animal and equine veterinary practices in order to focus on production animal health and welfare.
From now, the production animal business - which includes veterinary practices providing services to pig, poultry, dairy, beef, sheep, game bird producers and small holders - will be known under the umbrella brand of Origin.
The company says that excellence and innovation in client service will continue to be the focus throughout the organisation.
Matt Dobbs, Managing Director of Origin said: "Origin is committed to supporting livestock farmers to enhance production by improving health and welfare. We have a unique group of vets, researchers, lab techs and paraprofessionals passionate about the success of UK agriculture, with other businesses committed to supporting the industry, joining us through the autumn.
"By focusing on supporting farmers, we will become a unique source of animal insight in livestock agriculture."
For more information, visit: http://www.westpointveterinarygroup.com
Four separate studies are included in the collection, reporting novel risk factors for the disease, identifying key differences between EGS and botulism (questioning the hypothesis that EGS is caused by neurotoxins from Clostridium botulinum), reporting a novel diagnostic technique and showing the value of monitoring weight loss to help predict whether individual horses with chronic EGS are likely to survive.
The publishers say that despite more than 100 years of research, supported predominantly by the The Moredun Foundation Equine Grass Sickness Fund (www.grasssickness.org.uk), the cause of EGS remains unknown. Since it almost exclusively affects grazing horses, a pasture derived neurotoxin is implicated. EGS causes gut paralysis as a result of damage to parts of the nervous system that control involuntary functions. Acute and sub-acute EGS is invariably fatal while around 55% of chronic cases can survive and return to a useful working life. The UK has the highest incidence of EGS in the world; indeed it is estimated that the disease kills between 1 and 2% of horses in the United Kingdom annually. Cases are more common in spring.
In terms of risk factors, the study ‘Equine grass sickness in Scotland: A case-control study of environmental geochemical risk factors’ suggests that the high incidence of the disease in Eastern Scotland may be partly associated with the particular composition of macro and trace elements in the soil in the fields on which horses graze. Further work is required to determine whether interventions to alter concentrations of particular elements in soil could potentially reduce the risk of EGS.1
A second study identified key differences between EGS and botulism, which questions the currently favoured hypothesis that EGS is caused by neurotoxins from Clostridium botulinum, a bacterium which commonly inhabits soil. The study ‘Equine grass sickness, but not botulism, causes autonomic and enteric neurodegeneration and increases soluble N-ethylmaleimide-sensitive factor attachment receptor protein expression within neuronal perikarya’ suggests that EGS is unlikely to be caused by neurotoxins from this bacterium and concludes that further investigation of an alternative cause for EGS is needed.2
While the majority of horses with EGS can be readily diagnosed by experienced veterinary surgeons, some cases present a diagnostic challenge. Indeed the only way to definitively diagnose the disease in a live horse is to demonstrate the characteristic degeneration of nerves within biopsies of the intestine. Unfortunately these biopsies can only be collected by performing abdominal surgery under general anaesthesia. In the study ‘Neuronal chromatolysis in the subgemmal plexus of gustatory papillae in horses with grass sickness’ characteristic degeneration of nerves was identified in small biopsies collected from tongues of EGS horses during post mortem examination. Examination of these biopsies accurately differentiated control horses from EGS cases. While further validation of this technique is required, it could potentially provide a relatively non-invasive method of confirming the diagnosis in a live horse.3
While around 55% of horses with chronic EGS survive, objective criteria for predicting survival of these cases are currently lacking. The study ‘Bodyweight change aids prediction of survival in chronic equine grass sickness’ reported that non-survivors had greater rate and magnitude of bodyweight loss than survivors. Survival prediction curves were published to allow veterinary surgeons and horse owners to use body weight data to help determine whether an individual horse with chronic EGS was likely to survive or die.4
Professor Bruce McGorum, Head of the Equine Section at the Royal (Dick) School of Veterinary Studies & Roslin Institute in Edinburgh, has been leading much of the research. He said: "Given that our recent research suggests that EGS is unlikely to be caused by neurotoxins from Clostridium botulinum we are now moving on to determine whether EGS is caused by ingestion of mycotoxins produced by pasture fungi. We are very pleased that The Horse Trust (www.horsetrust.org.uk) has provided funding for this three-year investigation."
Professor Celia Marr, Editor of the Equine Veterinary Journal said: “While the cause of equine grass sickness continues to evade us, these papers present an optimistic step in the right direction for the eventual prevention of this dreadful disease. It is only with the support of the Moredun Foundation Equine Grass Sickness Fund and more recently that of The Horse Trust that our world-leading veterinary researchers are able to continue to unravel the mystery.”
The EVJ equine grass sickness collection can be downloaded at http://bit.ly/2dC7Drr
References
The survey is conducted every four to five years and asks vets to answer questions about a variety of subjects including demographic data (for example, socio-economic background, educational attainment, race/ethnicity, disability), work-related data (for example, employment status, location of workplace, type of workplace, hours of work, position in practice) and information about professional achievement (for example, hours of continuing professional development (CPD) undertaken and extra qualifications earned).
The survey, which is conducted on the College’s behalf by the Institute for Employment Studies, also ask respondents about their views on different aspects of their profession, including career plans, challenges facing the profession, and wellbeing.
This year, the survey also asks for your view of the RCVS, including its values, how it should communicate, and what it should prioritise in future years.
Lizzie Lockett, RCVS CEO (pictured right), said: "The results of the Surveys form a very important ‘snapshot’ of the profession at a given point in time, but they also prove useful for years to come in terms of how the College develops its regulatory and educational policy, the areas it chooses to focus on and the issues it chooses to tackle.
"The ensuing reports are also used by a myriad of other individuals, such as those in academia, government and representative bodies, as well as journalists. It’s therefore really important that we have as accurate a picture as possible. So although completing the Surveys is entirely voluntary, we strongly encourage members of the professions to take the time to complete them. It will, ultimately, help the development of appropriate and supportive policies for your profession."
In addition to the main survey, there will be an additional survey for MsRCVS who practise overseas. This survey aims to better understand why they continue to retain their MRCVS status, what this status means in the countries in which they work, global attitudes towards the RCVS and how the College could improve its communication with them.